< 生产厂家价格 >

邻溴溴苄

邻溴溴苄用途

【用途一】
用于有机合成
【用途二】
医药中间体。

点击显示

邻溴溴苄名称

[ CAS 号 ]:
3433-80-5

[ 中文名 ]:
2-溴溴苄

[ 英文名 ]:
4-Bromobenzyl bromide

[中文别名 ]:

[英文别名 ]:

p-Bromobenzyl-bromide
a,o-dibromotoluene
Benzene, 1-bromo-2-(bromomethyl)-
Benzene, 1-bromo-4- (bromomethyl)-
1-Bromo-2-(bromomethyl)benzene
4-Bromobenzyl bromide
|A,2-Dibromotoluene
ortho-2-bromo-benzyl bromide
α,p-Dibromotoluene
MFCD00000173

邻溴溴苄物理化学性质

[ 密度 ]:
1.9±0.1 g/cm3

[ 沸点 ]:
253.0±15.0 °C at 760 mmHg

[ 熔点 ]:
29-32 °C(lit.)

[ 分子式 ]:
C₇H₆Br₂

[ 分子量 ]:
249.930

[ 闪点 ]:
118.0±19.6 °C

[ 精确质量 ]:
247.883606

[ LogP ]:
3.69

[ 外观性状 ]:
白色至灰白色粉末

[ 蒸汽压 ]:
0.0±0.5 mmHg at 25°C

[ 折射率 ]:
1.606

[ 储存条件 ]:
0-6°C

邻溴溴苄MSDS

邻溴溴苄安全信息

[ 符号 ]:

GHS05

[ 信号词 ]:
Danger

[ 危害声明 ]:
H314

[ 警示性声明 ]:
P280-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
C:Corrosive

[ 风险声明 (欧洲) ]:
R23;R34;R37

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S45-S22

[ 危险品运输编码 ]:
UN 3261 8/PG 3

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
29036990

邻溴溴苄合成路线

邻溴溴苄上下游产品

邻溴溴苄上游产品

邻溴溴苄下游产品

邻溴溴苄制备

用日光灯照射反应锅内的邻溴甲苯,在160~180℃慢慢滴加溴素,尾气用水吸收,加完后,继续反应0.5h。减压排尽溴化氢及低沸物(120℃,<8.0kPa),降温至40℃以下,出料,得邻溴苄基溴。

点击显示

邻溴溴苄海关

[ 海关编码 ]: 2903999090

[ 中文概述 ]:
2903999090 其他芳烃卤化衍生物. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:5.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%

邻溴溴苄文献

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

J. Comb. Chem. 11(1) , 34-43, (2009)

For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib...

Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.

J. Comb. Chem. 11 , 14-33, (2009)

Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa...

Synthesis of quinazolines and tetrahydroquinazolines: copper-catalyzed tandem reactions of 2-bromobenzyl bromides with aldehydes and aqueous ammonia or amines.

Chem. Asian J. 9(3) , 739-43, (2014)

An efficient synthesis of diversely substituted quinazolines and 1,2,3,4-tetrahydroquinazolines through copper-catalyzed tandem reactions of the readily available 2-bromobenzyl bromides, aldehydes, an...

更多文献